Happy Pride Month!

Welcome To The Week In Review.

1.  Drug Prices Are Too High And Patients Pay The Price

 2.   The Truth About The Inflation Reduction Act 

3. The Looming Question Of Paying For Cell And Gene Therapies  

BONUS: William Feldman and Aaron Kesselheim’s new Washington Post op-ed shines light on yet another way drug companies abuse our patent system to protect lucrative monopolies at the cost of patient health and financial well-being. Worth a read!

Have a great weekend!